AeroRx Therapeutics
PrivateLast Round
Series A
Oct 7, 2025
Total Funding Raised
$27M
Company Overview
AeroRx Therapeutics operates in Healthcare & Life Sciences and is based in La Jolla, California. Its latest recorded funding round was a Series A round in October 2025.
AeroRx Therapeutics is a biotechnology company that develops proprietary, nebulized combination drug therapies for the treatment of chronic respiratory diseases such as chronic obstructive pulmonary disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AeroRx Therapeutics Comparables
Compare AeroRx Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Merck & Co., Inc. | 76% | |
| Sumitomo Pharma Co., Ltd. | 72% | |
| Zymeworks Inc. | 72% |
For institutional investors. Book with your work email.
AeroRx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 7, 2025 | ||||
| Seed | Apr 1, 2024 |
For institutional investors. Book with your work email.
AeroRx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alexandria Venture Investments | Series A |
| Avalon BioVentures | Series A |
| Correlation Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 3, 2025
Novel bronchodilation treatment for COPD moving to late-stage trials.
- Oct 7, 2025
$21M round completed.
For institutional investors. Book with your work email.
AeroRx Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AeroRx Therapeutics's valuation, stock price, and market status.
Is AeroRx Therapeutics a public or private company?
AeroRx Therapeutics is a private company.
What is the current stock price of AeroRx Therapeutics?
AeroRx Therapeutics is a private company, so its shares have no public market price. Caplight tracks AeroRx Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AeroRx Therapeutics worth (valuation)?
Valuation information for AeroRx Therapeutics is not publicly available.
Can I buy AeroRx Therapeutics stock?
AeroRx Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AeroRx Therapeutics's last funding round?
AeroRx Therapeutics's most recent funding round was Series A on October 7, 2025.
Who are the main investors in AeroRx Therapeutics?
Key investors in AeroRx Therapeutics include Avalon BioVentures.
Will AeroRx Therapeutics IPO soon?
No public IPO plans have been announced for AeroRx Therapeutics.
How can I track AeroRx Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in AeroRx Therapeutics's shares on secondary markets.